Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;89(1):105282.
doi: 10.1016/j.jbspin.2021.105282. Epub 2021 Sep 29.

SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150

Simon Cadiou  1 , Aleth Perdriger  2 , Samuel Ardois  3 , Jean-David Albert  4 , Olivia Berthoud  2 , Alain Lescoat  5 , Pascal Guggenbuhl  4 , François Robin  4
Affiliations
Comment

SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150

Simon Cadiou et al. Joint Bone Spine. 2022 Jan.
No abstract available

Keywords: COVID-19; Giant cell arteritis; Polymyalgia rheumatica; SARS-CoV-2; Vaccine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Patient's timelines of vaccines and PMR or GCA symptoms.
Fig. 2
Fig. 2
PET-CT of patient no 2. A. PET-CT at diagnosis in December 19, showing slight hypermetabolism of glenohumeral and coxofemoral joints without vascular hypermetabolism. B and C. PET-CT 2 years later and 23 days after her first dose of COVID19 vaccine, showing a panaortic and supra-aortic vasculitis.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Manzo C., Castagna A., Ruotolo G. Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? Joint Bone Spine. 2021;88:105150. - PMC - PubMed
    1. Riera-Martí N., Romaní J., Calvet J. SARS-CoV-2 infection triggering a giant cell arteritis. Med Clin (Engl Ed) 2021;156:253–254. - PMC - PubMed
    1. Tharmarajah E., Buazon A., Patel V., et al. IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression. J Infect. 2021;82:178–185. - PMC - PubMed
    1. Spiera R., Unizony S.H., Bao M., et al. Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial. Semin Arthritis Rheum. 2021;51:469–476. - PubMed
    1. Barbhaiya M., Levine J.M., Bykerk V.P., et al. Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Ann Rheum Dis. 2021 doi: 10.1136/annrheumdis-2021-220732. [annrheumdis-2021-220732] - DOI - PubMed

Substances